Viewing data from:

CLOMIPRAMINE HYDROCHLORIDE

ANDA

CLOMIPRAMINE HYDROCHLORIDE | A216440 | AUROBINDO PHARMA LTD

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: ANAFRANIL(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 9 NDCs

Highest NADAC/Unit

$0.3113

per ea

Lowest NADAC/Unit

$0.1824

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
59651038390CLOMIPRAMINE 75 MG CAPSULE	$0.3113	EA	Generic	—	2026-06-17
59651038301CLOMIPRAMINE 75 MG CAPSULE	$0.3113	EA	Generic	—	2026-06-17
59651038330CLOMIPRAMINE 75 MG CAPSULE	$0.3113	EA	Generic	—	2026-06-17
59651038230CLOMIPRAMINE 50 MG CAPSULE	$0.2257	EA	Generic	—	2026-06-17
59651038201CLOMIPRAMINE 50 MG CAPSULE	$0.2257	EA	Generic	—	2026-06-17
59651038290CLOMIPRAMINE 50 MG CAPSULE	$0.2257	EA	Generic	—	2026-06-17

Showing 6 of 9 NDCs.

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain7 active DMFs2 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

LUNDBECK PHARMACEUTICALS ITALY SPACLOMIPRAMINE HYDROCHLORIDE

DMF 88641990

SIGMA ALDRICH IRELAND LTDCLOMIPRAMINE HYDROCHLORIDE

DMF 109491994

TARO PHARMACEUTICAL INDUSTRIES LTDCLOMIPRAMINE HYDROCHLORIDE USP

DMF 130211998

BIOPHORE INDIA PHARMACEUTICALS PVT LTDCLOMIPRAMINE HYDROCHLORIDE

DMF 308142016

RL FINE CHEM PVT LTDCLOMIPRAMINE HYDROCHLORIDE

DMF 319422017

SUN PHARMACEUTICAL INDUSTRIES LTDCLOMIPRAMINE HYDROCHLORIDE USP

DMF 329962018

MANKIND PHARMA LTDCLOMIPRAMINE HYDROCHLORIDE USP

DMF 349352020

IROPHARM LTDInactiveCLOMIPRAMINE HYDROCHLORIDE

DMF 80471989

EVONIK TECHNOCHEMIE GMBHInactiveCLOMIPRAMINE HYDROCHLORIDE

DMF 131271998

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 25MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Mar 20, 2023

No patent or exclusivity listings for this strength.

#002 — 50MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Mar 20, 2023

#003 — 75MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Mar 20, 2023